Skip to main content

Table 3 Annual incidence rates per 100 person-years of non-AIDS events ranked from most to least frequent (ANRS CO3 Aquitaine and IPEC/FIOCRUZ cohorts combined)

From: AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000–2008: hospital-based cohort studies

  

2000

2001

2002

2003

2004

2005

2006

2007

2008

P-value

Total # of events

1

Bacterial

4.50

4.35

3.69

3.93

3.91

3.52

3.65

3.73

3.64

0.12

1602

2

Psychiatric

2.39

1.89

1.64

1.70

2.09

1.69

1.85

1.42

1.34

< 0.01

727

3

Hepatic

1.21

1.97

1.12

1.14

1.29

1.56

1.37

1.35

1.36

0.61

572

4

Viral

2.33

1.32

1.51

1.16

1.14

0.95

0.69

0.71

1.06

< 0.01

481

5

Hematological

0.90

1.63

1.27

1.23

1.34

1.01

1.00

0.93

1.15

0.51

479

6

Neurological

1.40

1.89

1.10

1.30

0.94

1.07

0.79

0.60

0.99

< 0.01

450

7

Digestive

1.70

1.48

0.88

1.21

0.86

0.99

1.00

0.76

0.79

< 0.01

433

8

Cardiovascular

0.93

1.19

0.76

0.91

0.70

0.64

0.88

0.98

1.10

0.82

375

9

Parasitic

1.15

0.83

0.66

1.07

0.79

0.49

0.52

0.66

0.49

< 0.01

298

10

Signs/syndromes

0.90

0.67

0.24

0.40

0.40

0.60

0.42

0.73

0.35

0.32

215

11

Renal

0.63

0.26

0.51

0.35

0.37

0.45

0.44

0.76

0.49

0.26

201

12

Rheumatologic

0.41

0.39

0.37

0.21

0.22

0.39

0.46

0.62

0.39

0.24

163

13

Endocrine

0.44

0.57

0.22

0.42

0.44

0.47

0.23

0.42

0.30

0.33

160

14

Respiratory

0.63

0.44

0.56

0.37

0.15

0.23

0.25

0.49

0.41

0.22

160

15

Dermatological

0.58

0.52

0.39

0.47

0.26

0.29

0.27

0.35

0.25

< 0.01

150

16

Malignancies

0.36

0.47

0.17

0.51

0.09

0.16

0.29

0.38

0.46

0.73

134

17

Other

0.44

0.34

0.27

0.23

0.13

0.14

0.06

0.20

0.11

< 0.01

83

18

Ophthalmological

0.08

0.39

0.02

0.02

0.09

0.02

0.08

0.09

0.11

0.22

40

19

Trauma

0.08

0.00

0.10

0.02

0.00

0.04

0.13

0.05

0.11

0.25

26

20

Gynecological

0.03

0.08

0.02

0.02

0.02

0.06

0.00

0.02

0.04

0.52

13

21

In situ neoplasia

0.03

0.00

0.00

0.02

0.00

0.00

0.00

0.00

0.00

NA

2